Product Information
Name:NCX899
Brand:Biosynth
Description:NCX899 is a novel drug that binds to the AT1 receptor and blocks the signaling of angiotensin II. It is an antagonist that has been shown to reduce blood pressure in animal models by preventing the binding of angiotensin II to its receptors in the carotid artery, thereby reducing vascular tone. The pharmacokinetics of NCX899 were studied in rats and dogs. The compound was found to be well absorbed after oral administration, with a tmax at 1-2 hours and a half-life of 3-4 hours. In rats, NCX899 showed inhibition of angiotensin converting enzyme (ACE) activity and tissue ACE levels. In addition, it was found to have high bioavailability, with only low plasma protein binding (less than 10%).
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:479.5 g/mol
Formula:C23H33N3O8
Purity:Min. 95%
Technical inquiry about: NCX899
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.